1/97
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
stroke ("brain attack")
sudden impairment in brain function, sudden paralysis or sensation
ischemic, hemorrhagic
two types of stroke
ischemic
stroke caused by blockage of a blood vessel due to a clot; includes subtypes of thrombotic and embolic
hemorrhagic
stroke caused by a ruptured blood vessel
2
the human brain makes up about ?% of body weight
15-20
the human brain receives about ?% of cardiac output
20
the human brain consumes about ?% of resting O2
gray
about 2/3 of the normal cerebral blood flow (CBF) is in the (gray/white) matter
8
? seconds of interruption of blood flow will lead to unconsciousness
face (smile/symmetry)
What does the F stand for in FAST acronym for spotting a stroke?
arm (ask person to raise both arms)
What does the A stand for in FAST acronym for spotting a stroke?
speech (ask person to speak simple sentence)
What does the S stand for in FAST acronym for spotting a stroke?
time (time lost is brain lost)
What does the T stand for in FAST acronym for spotting a stroke?
SHAME
acronym for risk factors of stroke
smoking
What does the S stand for in SHAME acronym for stroke risk factors?
hypertension
What does the H stand for in SHAME acronym for stroke risk factors?
atrial fibrillation
What does the A stand for in SHAME acronym for stroke risk factors?
male
What does the M stand for in SHAME acronym for stroke risk factors?
elderly
What does the E stand for in SHAME acronym for stroke risk factors?
amphipathic, apo-lipoproteins
lipids must bind to (hydrophilic/hydrophobic/amphipathic) proteins called ? to be transported in the blood
lipoproteins
protein-and-lipid substances in the blood that carry fats and cholesterol; classified according to size, density, and chemical composition
chylomicrons (CM)
lowest density lipoproteins
CM, VLDL, IDL, LDL, HDL, FFA
the six lipoprotein forms based on densities, in order from lowest to highest
pancreatic lipase
digests triacylglycerols (triglycerides/neutral fat) into fatty acids + monoacylglycerol, which can be absorbed by enterocytes (intestinal mucosal cells)
enterocytes (intestinal mucosal cells)
nascent chylomicrons are formed in ?
triacylglycerols, apolipoprotein
in enterocytes, ? are resynthesized and added to ? to form nascent chylomicrons
lacteal
the lymphatic vessels of the small intestine that absorb digested fats
exocytosis
nascent chylomicrons are transported from enterocytes to the central lacteal via ?
adipose, muscle, liver
chylomicrons deliver ~80% to ? tissue, ? tissue, and peripheral tissues; ~20% to the ?
HDL
the nascent CM is rapidly modified into CM by combining apoE + apoC-II from circulating ?
apoC-II
an apoprotein that is important for the metabolism of lipids in the CM b/c it activates lipoprotein lipase
lipoprotein lipase (LPL)
an enzyme that hydrolyzes triglycerides in lipoproteins into three fatty acids and monoacylglycerol
adipocytes
lipoprotein lipase (LPL) is mainly produced by ?
capillary, adipose, cardiac, skeletal, lactating mammary
LPL resides on the ? walls mainly on ? tissue, ? and ? muscles, and ? glands
lipogenesis
the monoacylglycerol and fatty acids from the hydrolyzed triacylglycerol are transported to adipocytes, where they promote ?
increases
LPL is insulin-sensitive--insulin (increases/decreases) LPL activities
apoC-II, HDL
after being degraded by LPL, CM decrease in size and increase in density -> ? is returned to the ? -> the remaining particle is called a "CM remnant"
liver
CM remnants in the blood are transported to the ?
leftover lipids
CM remnants deliver ? to the liver
hepatocytes (liver)
What type of cells produce VLDL?
fats, carbohydrates
the dietary intake of both ? and ?, in excess of the needs of the body, leads to the conversion into triacylglycerols in the liver
liver, peripheral, muscle, adipose
the function of VLDL is to transport endogenously synthesized triacylglycerols from the ? to ? tissues (mainly ? and ? tissue)
apoC
nascent VLDL released from the liver acquires ? and apoE from circulating HDL
non-alcoholic fatty liver (NAFLD)
a high rate of liver lipogenesis (from high lipid or carb intake) will exceed liver production of VLDL, leading to ? disease
cholesterol
LDL is made up ~80% by lipids--mostly ?
cholesterol, peripheral (liver 75%, adrenals, gonads, blood vessels, adipose tissue)
the primary function of LDL is to provide ? to ? tissues
insulin, LDL
? and tri-iodothyronine (T3) increase the binding of ? to liver cells -> cholesterol is eliminated via bile
diabetes
? or hypothyroidism -> hypercholesterolemia -> high risk of atherosclerosis in primates (b/c that cholesterol can't be metabolized by the liver)
liver
HDLs are synthesized de novo in the ? and small intestine, as protein-rich particles
reverse cholesterol transport
a process in which HDL molecules attract cholesterol and carry it back to the liver, where it is converted into bile acids and eventually excreted through feces
atheroma
the lipid deposits in intima of arteries, producing a yellow swelling on the endothelial surface
intima
inner layer of blood vessels containing endothelial cells, the underlying extracellular matrix, and a smattering of smooth muscle cells
atherosclerosis
disease in which plaque builds up inside the arteries
increased, NO, adhesion, chemo-attractants
characteristics of endothelial dysfunction: (increased/decreased) vascular permeability, decreased synthesis and/or release of ?, increased secretion of ? molecules, and increased secretion of ?
macrophages
adhesion molecules include VCAM-1, which mediates the adhesion of monocytes (?), lymphocytes, eosinophils, and basophils to the vascular endothelium
chemo-attractants
recruit inflammatory cells to areas of lipid accumulation
LDL, monocytes
the intact and yet dysfunctional endothelium becomes sticky -> infiltration of plasma ? and ?
decreased, increased
atherosclerosis risk factors result in (increased/decreased) NO production, and (increased/decreased) free radicals
antioxidants
important for reducing risks of atherosclerosis
shear stress, lipids (LDL), inflammatory
turbulent blood flow creates endothelial ? -> decreased NO production -> vasoconstriction -> infiltration of ? and ? cells
shear stress
endothelial ? is the friction of blood against the endothelium, which is exacerbated by hypertension
vascular inflammation
endothelial dysfunction -> ? -> accumulation of lipids and cellular debris in intima; this plays a key role in atherosclerosis
in
atherosclerotic deposits are (in/on) vessel walls
ROS, oxi-LDL
endothelial dysfunction recruits LDL which passes into the vascular intima -> LDL is oxidized by ? into ? (pro-inflammatory)
endothelial, adhesion, monocytes
oxi-LDL activates ? cells through the induction of the cell surface ? molecules -> ? are adhered then entered across the endothelium to the sub-endothelial matrix
macrophages, oxi-LDL
after blood monocytes infiltrate into the subendothelial area of the vascular wall, they differentiate into ? which then take up ?, forming foam cells
scavenger
foam cells contain ? LDL receptors (no feedback) -> more and more cholesterol in foam cells -> secrete more cytokines -> inflammation -> cell death
foam cells
lipid-loaded white blood cells that have surrounded large amounts of a fatty substance, usually cholesterol, on the blood vessel walls
CRP (C-reactive protein)
substance that is produced by the liver and released to the blood that increases in the presence of inflammation in the body
biomarker, mediator
CRP functions as a ? and a ? in pathogenesis of atherosclerosis
biomarker
an individual protein that is uniquely produced in a diseased state
(inflammatory) mediator
a chemical that impacts the immunoinflammatory process causing either exacerbation or reduction
macrophages, adipocytes
CRP is synthesized by the liver in response to factors released by ? and ?
acute
the levels of CRP increase during ? inflammation
smooth muscle cells (SMC), fatty, extracellular matrix
foam cells secrete pro-inflammatory cytokines -> ? proliferation and migration to the intima, where they secrete cytokines; also, increased ? deposits and formation of ? in the intima
stable
atheroma characterized by a thick fibrous cap, small lipid core, more SMC, and well-preserved endothelium
vulnerable
atheroma characterized by a thin fibrous cap, large and necrotic lipid core -> more inflammatory cells -> eroded endothelium
proteolytic enzymes
heavily infiltrating foam cells secrete ?, degrade the collagen-rich cap matrix, and cause the gradual loss of SMCs and collagen from the fibrous cap
pathological thrombosis (formation of blood clot)
endothelial disruption due to rupture -> platelet aggregation -> activation of coagulation cascade -> conversion of fibrinogen into fibrin -> blood clot formation -> ?
brain
What part of the body does stroke involve?
weakness, numbness, blurred, headache
symptoms of stroke include: one-sided ? and ?, speech difficulties, ? vision, and terrible ?--does not include chest pain
mini-stroke (transient ischemic attack/TIA)
equivalent to "angina" of the brain; reversible focal brain dysfunction due to ischemia; transient stroke symptoms that last from seconds to hours; it is a key opportunity to prevent stroke (permanent damage)
BP, heart, arteries
causes of TIA are essentially the same as those for stroke and heart diseases: high ?, ? diseases, and narrowing of ?
dissolution
TIA mechanism: blood clot forms -> body recognizes the presence of clot -> triggers clot ? mechanism -> vessel reopens -> symptoms go away
85
about ?% of strokes are ischemic strokes
HTN (hypertension), DM
about 2/3 of thrombotic strokes are associated with ? and ?
embolus
a clot that breaks loose and travels through the bloodstream
hypertension
the most important cause of intracerebral hemorrhage, which commonly occurs during activity
glutamate
stroke greatly increases release of the NT ? -> overstimulation of receptors -> neurodegeneration and neuronal damage
glutamate
the most prominent NT in the body; the brain's main excitatory NT, present in >50% of nervous tissue; the precursor for GABA, the brain's main inhibitory NT
postsynaptic
glutamate is responsible for neurons' (presynaptic/postsynaptic) excitation, and for memory formation, learning, and regulation
Ca2+, excitotoxicity
glutamate-R binding activates the R's and opens ion channels coupled to the R -> allows extracellular ? to pass into the intracellular cytosol -> ? -> neurodegeneration and neuronal damage
microglia, astrocytes, cytokines, metalloproteases
initial ischemic event -> excitotoxicity -> ? and ? activated + increased neutrophil infiltration -> secrete ? and matrix ? -> neuronal death
t-Pa (tissue plasminogen activator)
a naturally occurring enzyme that is released into the blood very slowly (days) by the damaged endothelium and breaks down blood clots and clears blocked blood vessels; treatment for acute ischemic stroke and heart attack
fibrinolysis
breakdown of a clot; a normal process after damaged vessel is repaired
liver
plasminogen is produced in the ? -> blood
plasminogen activators (PAs)
convert plasminogen into plasmin (active)
plasmin
an enzyme that dissolves the fibrin of blood clots